London has emerged as a global powerhouse in the life sciences sector, anchoring the UK's "Golden Triangle" alongside Oxford and Cambridge. As a leading Clinical Genomics Analysis Systems Supplier & Exporter, we recognize that London’s ecosystem is unique, blending world-class academic research at institutions like UCL and Imperial College with the vast clinical reach of the National Health Service (NHS). This synergy creates a high demand for sophisticated genomic analysis tools that can handle massive datasets while meeting the stringent MHRA (Medicines and Healthcare products Regulatory Agency) guidelines.
The industrial status of genomics in London is characterized by a shift towards decentralized testing and the integration of artificial intelligence into clinical workflows. From the King’s Cross Knowledge Quarter to the London Cancer Hub, the city is at the forefront of implementing Whole Genome Sequencing (WGS) into routine patient care. Our systems are specifically engineered to interface with these digital health infrastructures, providing the "Information Gain" necessary for precision oncology, rare disease diagnostics, and pharmacogenomics.
Manufacturing Sqm
Expert Employees
Global Export Zones
Certified Quality
The global clinical analysis landscape is undergoing a paradigm shift. We are moving away from traditional batch testing toward automated, high-throughput, and real-time analytical systems. Global enterprises—from private diagnostic chains in the Middle East to public health labs in North America—are increasingly seeking procurement partners who offer more than just hardware. They require end-to-end solutions that include automated nucleic acid extraction, bioinformatics pipelines, and long-term technical support.
Current Market Drivers:
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Our product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Operating in London requires a deep understanding of Local Compliance and UKCA markings. As a strategic supplier, we provide comprehensive documentation and validation protocols (IQ/OQ/PQ) to ensure that every clinical genomics analysis system meets the requirements of UKAS-accredited laboratories. Our localized support includes:
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
Our roadmap for 2025 and beyond includes the integration of Edge Computing into our analysis systems, allowing for faster localized data processing without relying on cloud latency. We are also expanding our Pathogen Detection portfolio to include multi-plex respiratory panels and antimicrobial resistance (AMR) profiling—technologies critical for London's public health preparedness.
Partner with a world-class supplier of genomics and clinical analysis systems. Experience the BioX advantage in precision medicine.
BioX Medical
